Yun-Lian Lin

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Academia Sinica, Joben Bio-Medical Co., Ltd., Axr Pharma Inc.. Active years: 2008-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun-Lian Lin. Retrieved from https://idiyas.com/inventor/yun-lian-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 78.6

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Kaohsiung, TW (2014 - 2015)
Taipei, TW (2008 - 2023)

Company Filing History:

Joben Bio-Medical Co., Ltd.

China Medical University

patents

6. 1 out of 1,247

National Yang Ming Chiao Tung University

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12465612 - Method of using extract of Dendrobii Caulis and method of protecting eye (2025-11-11),

2. 12397034 - Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons (2025-08-26),

3. 11576918 - Pharmaceutical composition and extract of Dendrobii Caulis with eye care effect and uses of preparing the same thereof (2023-02-14),

4. 11234993 - Method for treatment of cellular senescence (2022-02-01),

5. 10342818 - [object Object] (2019-07-09),

6. 10301348 - Compounds for use in prevention and treatment of neurodegenerative diseases and pain (2019-05-28),

7. 10117890 - Methods and compositions for treating pain (2018-11-06),

8. 9744205 - Alcohol extract of dehulled adlay seeds for treating breast cancer (2017-08-29),

9. 8945638 - Alcohol extract of dehulled adlay seeds for treating gastric ulcer and/or stomach cancer (2015-02-03),

10. 8686031 - Flavonoids and uses thereof (2014-04-01),

11. 8648215 - Spiroenone and uses thereof (2014-02-11),

12. 8633238 - Lactams and uses thereof (2014-01-21),

13. 8129357 - Method of making and using an adenosine analogue (2012-03-06),

14. 7351434 - [object Object] (2008-04-01),

Title: Innovations and Contributions of Inventor Yun-Lian Lin

Introduction

Yun-Lian Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in neurogenesis and eye care. With a total of 13 patents to his name, Lin's work has garnered attention for its innovative approaches to health and wellness.

Latest Patents

Among his latest patents, Lin has developed a pharmaceutical composition for promoting neurogenesis and a method for inhibiting the senescence of brain neurons. This invention utilizes an extract or an adenosine analog to promote neurogenesis, featuring ingredients such as gastrodin, gastrodigenin, parishins, N-(4-hydroxybenzyl) adenosine (T1-11), and 4-hydroxybenzaldehyde. The extract demonstrates anti-aging activity on nerve cells and can induce neurogenesis in the mouse hippocampus. Additionally, he has created a pharmaceutical composition and extract of Dendrobii Caulis with eye care effects, which includes a picrotoxane-type sesquiterpene as an active ingredient.

Career Highlights

Yun-Lian Lin has worked with notable institutions such as Academia Sinica and Joben Biomedical Co., Ltd. His experience in these organizations has allowed him to advance his research and develop innovative solutions in the pharmaceutical industry.

Collaborations

Lin has collaborated with esteemed colleagues, including Yijuang Chern and Wenchang Chiang. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Yun-Lian Lin's contributions to the field of pharmaceuticals, particularly in neurogenesis and eye care, highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and applications.

Profile summary based on public USPTO records.